2026 A Phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer
2015
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI